STOCK TITAN

Outset Medical to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Outset Medical (Nasdaq: OM), a medical technology company focused on reducing dialysis costs and complexity, has announced its plans to release Q2 2024 financial results on Wednesday, August 7, 2024, after market close. The company will host a conference call at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on the same day to discuss financial and operating results.

The call will be led by Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO. Interested participants can register online to receive dial-in numbers and a unique pin. Registration is recommended at least 15 minutes before the call. A live and archived webcast will be available on the company's investor relations website.

Outset Medical (Nasdaq: OM), un'azienda tecnologica medica focalizzata sulla riduzione dei costi e della complessità della dialisi, ha annunciato i suoi piani per rilasciare i risultati finanziari del Q2 2024 il mercoledì 7 agosto 2024, dopo la chiusura del mercato. La società terrà una conferenza telefonica alle 14:00 ora del Pacifico (17:00 ora dell'Est) lo stesso giorno per discutere dei risultati finanziari e operativi.

La chiamata sarà guidata da Leslie Trigg, Presidente e CEO, e Nabeel Ahmed, CFO. I partecipanti interessati possono registrarsi online per ricevere i numeri di accesso e un PIN unico. Si raccomanda di registrarsi almeno 15 minuti prima della chiamata. Un webcast dal vivo e archiviato sarà disponibile sul sito web delle relazioni con gli investitori della società.

Outset Medical (Nasdaq: OM), una empresa de tecnología médica centrada en reducir los costos y la complejidad de la diálisis, ha anunciado sus planes para publicar los resultados financieros del Q2 2024 el miércoles 7 de agosto de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica a las 2:00 p.m. hora del Pacífico (5:00 p.m. hora del Este) el mismo día para discutir los resultados financieros y operativos.

La llamada será liderada por Leslie Trigg, Presidente y CEO, y Nabeel Ahmed, CFO. Los participantes interesados pueden registrarse en línea para recibir los números de acceso y un PIN único. Se recomienda registrarse al menos 15 minutos antes de la llamada. Se dispondrá de una transmisión web en vivo y archivada en el sitio web de relaciones con inversores de la empresa.

Outset Medical(Nasdaq: OM)는 투석 비용과 복잡성을 줄이는 데 중점을 둔 의료 기술 회사로, 2024년 2분기 재무 결과2024년 8월 7일 수요일 시장 종료 후 발표할 계획이라고 발표했습니다. 회사는 같은 날 오후 2시 태평양 시간(오후 5시 동부 시간)에 재무 및 운영 결과를 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다.

이 통화는 Leslie Trigg, 회장 겸 CEONabeel Ahmed, CFO가 주도할 것입니다. 관심 있는 참가자는 온라인으로 등록하여 접속 번호와 고유 PIN을 받을 수 있습니다. 통화 15분 전까지 등록하는 것이 권장됩니다. 실시간 및 아카이브된 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공됩니다.

Outset Medical (Nasdaq: OM), une entreprise de technologie médicale axée sur la réduction des coûts et de la complexité de la dialyse, a annoncé ses projets de publier les résultats financiers du T2 2024 le mercredi 7 août 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 14h00 heure du Pacifique (17h00 heure de l'Est) le même jour pour discuter des résultats financiers et opérationnels.

La conférence sera animée par Leslie Trigg, Présidente et CEO, et Nabeel Ahmed, CFO. Les participants intéressés peuvent s'inscrire en ligne pour recevoir les numéros de composition et un code PIN unique. L'inscription est recommandée au moins 15 minutes avant l'appel. Un webinaire en direct et archivé sera disponible sur le site Web des relations investisseurs de l'entreprise.

Outset Medical (Nasdaq: OM), ein Medizintechnikunternehmen, das sich auf die Reduzierung von Kosten und Komplexität der Dialyse konzentriert, hat seine Pläne angekündigt, die Finanzergebnisse für das 2. Quartal 2024 am Mittwoch, den 7. August 2024, nach Börsenschluss zu veröffentlichen. Das Unternehmen wird am selben Tag um 14:00 Uhr pazifischer Zeit (17:00 Uhr östlicher Zeit) eine Telefonkonferenz abhalten, um die finanziellen und betrieblichen Ergebnisse zu besprechen.

Die Telefonkonferenz wird von Leslie Trigg, Vorsitzende und CEO, und Nabeel Ahmed, CFO, geleitet. Interessierte Teilnehmer können sich online registrieren, um Zugangsdaten und eine einzigartige PIN zu erhalten. Eine Registrierung wird empfohlen, mindestens 15 Minuten vor der Konferenz. Ein Live- und archivierter Webcast wird auf der Investor Relations-Website des Unternehmens verfügbar sein.

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on Wednesday, August 7, 2024.

On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, August 7, 2024. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Jim Mazzola

Investor Relations

jmazzola@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

When will Outset Medical (OM) release its Q2 2024 financial results?

Outset Medical (OM) will release its Q2 2024 financial results on Wednesday, August 7, 2024, after the close of trading.

What time is Outset Medical's (OM) Q2 2024 earnings conference call?

Outset Medical's (OM) Q2 2024 earnings conference call is scheduled for Wednesday, August 7, 2024, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time).

Who will host Outset Medical's (OM) Q2 2024 earnings call?

Leslie Trigg, Chair and CEO, and Nabeel Ahmed, CFO, will host Outset Medical's (OM) Q2 2024 earnings call.

How can I access Outset Medical's (OM) Q2 2024 earnings call?

You can access Outset Medical's (OM) Q2 2024 earnings call by registering online to receive dial-in numbers and a unique pin. A live and archived webcast will also be available on the company's investor relations website.

Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Stock Data

27.66M
52.09M
2.15%
96.56%
13.64%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
SAN JOSE